These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29557182)

  • 1. STK24 expression is modulated by DNA copy number/methylation in lung adenocarcinoma and predicts poor survival.
    Huang N; Lin W; Shi X; Tao T
    Future Oncol; 2018 Sep; 14(22):2253-2263. PubMed ID: 29557182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
    Chen D; Luo L; Liang C
    PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP4 expression independently predicts favorable survival in lung adenocarcinoma.
    Zhong M; Jiang Q; Jin R
    IUBMB Life; 2018 Jul; 70(7):670-677. PubMed ID: 29667299
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Zhang W; Li T; Hu B; Li H
    Technol Cancer Res Treat; 2020; 19():1533033820957030. PubMed ID: 33084541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL; Gong Y; Zhao DP
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LDHA upregulation independently predicts poor survival in lung adenocarcinoma, but not in lung squamous cell carcinoma.
    Yu C; Hou L; Cui H; Zhang L; Tan X; Leng X; Li Y
    Future Oncol; 2018 Oct; 14(24):2483-2492. PubMed ID: 29756998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
    Liu X; Chen L; Zhang T
    Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High BIRC7 Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer.
    Yang Y; Sun P; Xu W; Xia W
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818809694. PubMed ID: 30376767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of
    Wang D; Jia Y; Zheng W; Li C; Cui W
    Dis Markers; 2019; 2019():6019637. PubMed ID: 31885740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High
    Xie L; Dang Y; Guo J; Sun X; Xie T; Zhang L; Yan Z; Amin H; Guo X
    Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma.
    Wang L; Zhao H; Xu Y; Li J; Deng C; Deng Y; Bai J; Li X; Xiao Y; Zhang Y
    Int J Cancer; 2019 Apr; 144(7):1723-1734. PubMed ID: 30226269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
    Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H
    Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282
    [No Abstract]   [Full Text] [Related]  

  • 13. NFIX downregulation independently predicts poor prognosis in lung adenocarcinoma, but not in squamous cell carcinoma.
    Ge J; Dong H; Yang Y; Liu B; Zheng M; Cheng Q; Peng L; Li J
    Future Oncol; 2018 Dec; 14(30):3135-3144. PubMed ID: 30418046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
    Pan HX; Bai HS; Guo Y; Cheng ZY
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Expression of
    Hu P; Huang Y; Gao Y; Yan H; Li X; Zhang J; Wang Y; Zhao Y
    DNA Cell Biol; 2020 Apr; 39(4):522-532. PubMed ID: 32040344
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Hou L; Li Y; Wang Y; Xu D; Cui H; Xu X; Cong Y; Yu C
    Dis Markers; 2018; 2018():4108919. PubMed ID: 30420903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of TCF21 mRNA expression in patients with lung adenocarcinoma.
    Xiao J; Liu A; Lu X; Chen X; Li W; He S; He B; Chen Q
    Sci Rep; 2017 May; 7(1):2027. PubMed ID: 28515486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC22A16 upregulation is an independent unfavorable prognostic indicator in gastric cancer.
    Zhao W; Wang Y; Yue X
    Future Oncol; 2018 Sep; 14(21):2139-2148. PubMed ID: 29698084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated integrin α6 expression is involved in the occurrence and development of lung adenocarcinoma, and predicts a poor prognosis: a study based on immunohistochemical analysis and bioinformatics.
    Shen J; Xu J; Chen B; Ma D; Chen Z; Li JC; Zhu C
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1681-1693. PubMed ID: 31175464
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Yu J; Hou M; Pei T
    DNA Cell Biol; 2020 May; 39(5):890-899. PubMed ID: 32282228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.